SolarisRTC
Expert Team
Esther Abels
CEO and Founder SolarisRTC LLC, CEO and Co-Founder SolarisRTC Europe B.V.
Precision Medicine | Biomedical Regulatory Health Science Expert
After having been a management team and C suite member responsible for contribution to the overall business strategy and leading pharma services Esther Abels started her own advisory company SolarisRTC in 2023. Esther has a background in business strategy, commercialization, bridging R&D, proof of concept, socio / health economics and pivotal clinical validation studies used for registration purposes in different geographies, for both pharma and biotech products. She has over 25 years of regulatory, clinical and quality experience specializing in bringing products to clinical utility. She played a crucial role in getting a De Novo for Whole Slide Imaging devices, i.e., reclassified these devices from the highest risk class III to a moderate risk class II device in USA and getting the first digital pathology algorithms certified under IVDR in Europe.
Esther drives efforts for reimbursement in digital pathology and collaborations with different Pathology Associations. She was the president for the Digital Pathology Association (DPA) in 2022, chaired the DPA Regulatory and Standards Taskforce and facilitates FDA collaborations to drive regulatory and standard clarifications for interoperability and computational pathology in the field of digital pathology. Currently she is the chair of the DPA Pharma Taskforce to find general principles around implementing digital pathology to discover and develop new drugs, biomarkers and other tools to accelerate the development pipeline.
She is also a co-founder of the Alliance for Digital Pathology, now named Pathology Innovation Collaborative Community where she was co-leading the reimbursement workgroup.
Esther holds an MSc in Biomedical Health Science from Radboud University Nijmegen, The Netherlands.
Ingrid Abels
COO and Co-Founder SolarisRTC Europe B.V.
With a deep commitment to quality, precision, and people, Ingrid Abels plays a vital role in driving operational excellence at SolarisRTC. She brings a rare blend of financial acumen and quality management expertise, having successfully implemented and maintained ISO 9001 certification and built strong quality control systems. Her focus lies in execution—organizing, coordinating, and guiding clients through key operational steps with clarity and consistency.
Ingrid works closely with Esther to ensure the team stays aligned, timelines are met, and clients remain focused on moving forward efficiently. Her strength lies in keeping projects on track and translating plans into concrete actions.
She supports both early-stage innovators and established companies by streamlining execution and ensuring implementation is both human-centered and effective. Recently expanding her regulatory knowledge through certified training in IVDR and ISO for medical devices, she continues to build her domain expertise with focus and discipline.
At SolarisRTC, we believe progress is achieved through collaboration and execution. Ingrid is our engine—keeping momentum, managing day-to-day operations, and ensuring that ideas are delivered with care and precision. She is your dedicated partner in getting things done—with the patient always at the center.
SolarisRTC is proud to work with Regulatory & Clinical Affairs specialists.
Our specialists have an in-depth expertise in obtaining IVDR certification for Medical Device Software (MDSW) / Software as a Medical Device (SaMD) in the field of Digital Pathology, such as but not limited to:
- Authoring and executing Performance Evaluation Plans and reports,
- Authoring requirements and related test plans and reports,
- Developing intended use and labeling documents,
- Contributing to successful IVDR audits and
- Engineering of Digital Pathology algorithms.
We also provide Chief Medical Officer (CMO) solutions.
Our CMO is an academic oncologist with deep expertise in rare cancers, a fervent commitment to digital pathology, and a strong cross-functional approach that prioritizes scientific rigor and patient outcomes. He brings strategic insight from his leadership in research networks and scientific committees across national and international platforms.
Additionally, SolarisRTC includes lab expertise through our Director of Laboratory Strategy.
She is ABMGG board-certified in Clinical Molecular Genetics and Genomics, with a unique combination of academic and startup experience. Having successfully led CAP-accredited, CLIA-certified labs and implemented quality systems for LDTs, she now focuses on supporting clients in compliance for lab tests—ensuring regulatory alignment while embedding safety and reliability in diagnostic development.
SolarisRTC is proud to work with our trusted partners who have an in-depth expertise, such as but not limited to:
- Electronic Data Capturing development and Data Management
- Clinical Trial Operations and Management
- BioStatistics, and
- Contributing to successful IVDR audits and
- Medical Writing. Pathology algorithms.
